Article History
Received: 17 August 2022
Accepted: 13 December 2022
First Online: 16 February 2023
Competing interests
: J.A.D. is a cofounder of Caribou Biosciences, Editas Medicine, Scribe Therapeutics, Intellia Therapeutics and Mammoth Biosciences. J.A.D. is a scientific advisory board member of Vertex, Caribou Biosciences, Intellia Therapeutics, Scribe Therapeutics, Mammoth Biosciences, Algen Biotechnologies, Felix Biosciences, The Column Group, Sixth Street and Inari. J.A.D. is a Director at Johnson & Johnson, Altos and Tempus and has research projects sponsored by AppleTree Partners and Roche. All other authors declare no competing interests.